MICROCHEMISTRY and PROTEOMICS
显微化学和蛋白质组学
基本信息
- 批准号:7671830
- 负责人:
- 金额:$ 20.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-31 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAffinityAffinity ChromatographyAlanineAmino Acid SequenceAmino AcidsAnti-Bacterial AgentsAntibodiesAreaArginineBase SequenceBindingBiologicalBiological ProcessBiomedical ResearchBiotinylationCell ExtractsCellsChemicalsChemistryClassificationClinical ResearchCompanionsComplexCouplingDNA RepairDevelopmentDiseaseDissectionExhibitsFacility Construction Funding CategoryGenerationsGlutamineGlycineGoalsGrowthHigh Pressure Liquid ChromatographyImmunologicsIsotopesLabelLaboratoriesLengthLigandsMALDI-TOF Mass SpectrometryManualsMass Spectrum AnalysisMeasurementMembraneMemorial Sloan-Kettering Cancer CenterMethodsMethylationMicrochemistryModelingModificationMolecularMonoclonal AntibodiesMutationN-terminalNatureNormal tissue morphologyNucleic acid sequencingNumbersPatternPeptide Sequence DeterminationPeptide SynthesisPeptide VaccinesPeptidesPhasePhosphorylationPositioning AttributePost Translational Modification AnalysisPost-Translational Protein ProcessingProcessProtein AnalysisProtein Sequence AnalysisProteinsProteomicsPurposeQuality ControlRadioRadiolabeledReagentRelative (related person)ReportingResearchResearch PersonnelResearch PriorityResearch Project GrantsRetrievalSamplingScanningScreening procedureServicesSignal PathwaySpecific qualifier valueSpecificityStereoisomerStructureSurfaceTechniquesVaccinesWeightanalogbasecancer cellcell growthcrosslinkdisulfide bondenantiomerglycosylationimmunogenicinhibitor/antagonistinstrumentinstrumentationmolecular masspolypeptideprogramsprotein protein interactionradiotracerresearch studyresponsesenescencesulfationsynthetic peptide
项目摘要
The Microchemistry and Proteomics Facility (MPF) supports laboratory and clinical research programs at
MSKCC by (i) providing synthetic peptides and by (ii) performing mass spectrometric and amino acid
sequence analyses of proteins and peptides, generally for the purpose of identification, relative quantitative
analysis and post-translational modification (PTM) analysis. Synthetic molecules are made according to
specifications provided by the investigator. Samples submitted for identification (either single proteins or
mixtures), for PTM analysis or N-terminal sequencing are prepared by the lab requesting service.
Information on chemistries and instrumentation, and expert advice on experimental approaches are provided
by facility staff when needed.
The goal of proteomics is to analyze changing levels, local concentrations and post-translational
modifications of proteins in a cell, as well as to analyze higher-order networks of protein-protein interactions.
Proteins and protein modifications are critical in the complex signaling pathways and regulatory processes
underlying cell growth, division, differentiation, DNA repair, development, senescence, and in responses to
bioactive agents, genetic alterations and disease. Dissection of multi-component protein complexes is
therefore increasingly the focus of studies on molecular control mechanisms. Identification of unique
components provides a powerful approach to the selective retrieval and identification of the companions. The
impact that these services have provided, in facilitating research projects and enabling the timely
progression of high priority research, can be recognized throughout the reports of the several research
programs.
微量化学和蛋白质组学设施(MPF)支持实验室和临床研究计划,
MSKCC通过(i)提供合成肽和通过(ii)进行质谱和氨基酸分析,
蛋白质和肽的序列分析,一般用于鉴定,相对定量
分析和翻译后修饰(PTM)分析。合成分子是根据
研究者提供的质量标准。提交用于鉴定的样品(单一蛋白质或
混合物),用于PTM分析或N-末端测序,由请求服务的实验室制备。
提供了有关化学和仪器的信息,以及有关实验方法的专家建议
必要时由设施工作人员提供。
蛋白质组学的目标是分析变化的水平,局部浓度和翻译后
细胞中蛋白质的修饰,以及分析蛋白质-蛋白质相互作用的高阶网络。
蛋白质和蛋白质修饰在复杂的信号通路和调控过程中至关重要
潜在的细胞生长、分裂、分化、DNA修复、发育、衰老,以及对
生物活性剂、遗传改变和疾病。多组分蛋白质复合物的解剖是
因此,越来越多的研究的重点是分子控制机制。唯一标识
组件提供了一个强大的方法来选择性检索和识别的同伴。的
这些服务在促进研究项目和及时提供
高优先级研究的进展,可以在几项研究的报告中得到承认
程序.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL TEMPST其他文献
PAUL TEMPST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL TEMPST', 18)}}的其他基金
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
早期胰腺癌的蛋白质和蛋白水解活性生物标志物
- 批准号:
10090577 - 财政年份:2017
- 资助金额:
$ 20.2万 - 项目类别:
Immobilized protease activity tests for developing functional cancer biomarkers.
用于开发功能性癌症生物标志物的固定化蛋白酶活性测试。
- 批准号:
9089598 - 财政年份:2014
- 资助金额:
$ 20.2万 - 项目类别:
Immobilized protease activity tests for developing functional cancer biomarkers.
用于开发功能性癌症生物标志物的固定化蛋白酶活性测试。
- 批准号:
8663557 - 财政年份:2014
- 资助金额:
$ 20.2万 - 项目类别:
Immobilized protease activity tests for developing functional cancer biomarkers.
用于开发功能性癌症生物标志物的固定化蛋白酶活性测试。
- 批准号:
8847684 - 财政年份:2014
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7231867 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7293621 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7688689 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7496071 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7925814 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
Assessment of serum peptide profiling to detect cancer-specific patterns
评估血清肽谱以检测癌症特异性模式
- 批准号:
7921180 - 财政年份:2006
- 资助金额:
$ 20.2万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 20.2万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 20.2万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 20.2万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 20.2万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 20.2万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 20.2万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 20.2万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 20.2万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 20.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 20.2万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




